Sanofi, Regeneron lose US patent challenge to Amgen’s cholesterol drug – CNBC

Sanofi, Regeneron lose US patent challenge to Amgen’s cholesterol drug  CNBC

Biotech company Amgen said on Monday a U.S. jury confirmed the validity of patents on its cholesterol drug Repatha, rejecting a challenge by Regeneron …